Amended Statement of Ownership (sc 13g/a)
February 16 2021 - 6:31AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13G/A
Under
the Securities Exchange Act of 1934
(Amendment
No. 2)*
Minerva
Neurosciences, Inc.
(Name
of Issuer)
Common
Stock, $0.0001 par value per share
(Title
of Class of Securities)
603380106
(CUSIP
Number)
December
31, 2020
(Date
of Event Which Requires Filing of this Statement)
Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐
|
Rule
13d-1(b)
|
☐
|
Rule
13d-1(c)
|
☒
|
Rule
13d-1(d)
|
*
|
The
remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures
provided in a prior cover page.
|
|
|
The
information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section
18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the Notes).
|
|
|
|
|
CUSIP No. 603380106
|
|
13G
|
|
Page
2 of 5 Pages
|
|
|
|
|
|
|
|
1
|
|
NAMES
OF REPORTING PERSONS
Dr.
Remy Luthringer
|
2
|
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
☐ (b) ☐
|
3
|
|
SEC
USE ONLY
|
4
|
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
France
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED
BY EACH
REPORTING
PERSON WITH
|
|
5
|
|
SOLE
VOTING POWER
3,208,279
|
|
6
|
|
SHARED
VOTING POWER
0
|
|
7
|
|
SOLE
DISPOSITIVE POWER
3,208,279
|
|
8
|
|
SHARED
DISPOSITIVE POWER
0
|
9
|
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,208,279
|
10
|
|
CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐
|
11
|
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
7.5%
|
12
|
|
TYPE
OF REPORTING PERSON
IN
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP No. 603380106
|
|
13G
|
|
Page
3 of 5 Pages
|
Item
1(a).
|
Name
of Issuer:
|
Minerva
Neurosciences, Inc. (the “Issuer”)
Item
1(b).
|
Address
of Issuer’s Principal Executive Offices:
|
The
Issuer’s principal executive offices are located at 1601 Trapelo Road, Suite 286, Waltham, MA 02451.
Item
2(a).
|
Name
of Persons Filing:
|
Dr.
Remy Luthringer
Item
2(b).
|
Address
of Principal Business Office or, if None, Residence:
|
c/o
Minerva Neurosciences, Inc.
1601
Trapelo Road, Suite 286
Waltham,
MA 02451
France
Item
2(d).
|
Title
of Class of Securities:
|
Common
Stock, $0.0001 par value per share (the “Common Stock”)
603380106
Item
3.
|
If
this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
|
Not
applicable.
|
|
|
CUSIP No. 603380106
|
13G
|
Page
4 of 5 Pages
|
|
(a)
|
3,208,279
shares of Common Stock, which consists of (a) 926,604 shares of Common Stock beneficially owned by Wint2felden Holding SA, a company
wholly owned by Dr. Luthringer; (b) 66,490 shares of Common Stock owned by Dr. Luthringer himself, and (c) options to purchase
2,215,185 shares of common stock that are exercisable within 60 days of December 31, 2020.
|
|
(b)
|
Percent
of Class: 7.5%
|
|
(c)
|
Number
of shares as to which such person has:
|
|
(i)
|
sole
power to vote or to direct the vote: 3,208,279
|
|
(ii)
|
shared
power to vote or to direct the vote: 0
|
|
(iii)
|
sole
power to dispose or to direct the disposition: 3,208,279
|
|
(iv)
|
shared
power to dispose or to direct the disposition: 0
|
Item
5.
|
Ownership
of Five Percent or Less of a Class.
|
Not
applicable.
Item
6.
|
Ownership
of More than Five Percent on Behalf of Another Person.
|
Not
applicable.
Item
7.
|
Identification
and Classification of the Subsidiary which Acquired the Security Being Reported on By the Parent Holding Company or Control
Person.
|
Not
applicable.
Item
8.
|
Identification
and Classification of Members of the Group.
|
Not
applicable.
Item
9.
|
Notice
of Dissolution of Group.
|
Not
applicable.
Not
applicable.
|
|
|
|
|
CUSIP No. 603380106
|
|
13G
|
|
Page
5 of 5 Pages
|
SIGNATURES
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
|
|
|
|
Dated
February 16, 2021
|
|
|
|
|
By:
|
|
/s/
Dr. Remy Luthringer
|
|
|
|
Dr.
Remy Luthringer
|
|
Minerva Neurosciences (NASDAQ:NERV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Minerva Neurosciences (NASDAQ:NERV)
Historical Stock Chart
From Sep 2023 to Sep 2024